Axogen, Inc. Operating Leases, Future Minimum Payments, Due in Two Years
Axogen, Inc. (AXGN) had Operating Leases, Future Minimum Payments, Due in Two Years of $2.54 million as of 2018-12-31, per its 10-K filed 2020-02-24.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-02-24
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $2.54M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $991.33K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $165.12K.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Two Years $165.12K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $2.54M 10-K · filed 2020-02-24 |
| 2018-09-30 | $991.33K 10-Q · filed 2018-10-29 |
| 2018-06-30 | $165.12K 10-Q · filed 2018-08-01 |
| 2018-03-31 | $165.12K 10-Q · filed 2018-04-30 |
| 2017-12-31 | $182.25K 10-K · filed 2018-02-28 |
| 2017-09-30 | $437.90K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $437.90K 10-Q · filed 2017-08-02 |
| 2017-03-31 | $437.90K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $437.90K 10-K · filed 2017-03-01 |
| 2015-12-31 | $206.46K 10-K · filed 2016-02-29 |
| 2014-12-31 | $244.00K 10-K · filed 2015-03-05 |
| 2013-12-31 | $243.00K 10-K · filed 2014-03-06 |
| 2012-12-31 | $34.02K 10-K/A · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |